Skip to content

01530.HK

3SBio Inc.

HKSE · Healthcare · Biotechnology · CN

HKD 16.24
−0.31%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue26.9B17.7B9.1B7.8B6.9B
Cost of Revenue2.8B1.3B1.3B1.2B1.2B
Gross Profit24.1B16.3B7.8B6.6B5.7B
Operating Expenses
R&D Expense3.0B1.5B1.3B794.8M693.2M
SG&A Expense7.8B4.3B3.9B3.5B3.0B
General & Admin Expense942.6M641.9M501.9M480.8M384.7M
Selling & Marketing Expense5.4B3.6B3.4B3.0B2.6B
Other Expenses(98.6M)(2.9M)
Total Operating Expenses10.8B5.8B5.2B4.2B3.7B
Cost and Expenses13.6B7.2B6.5B5.4B4.8B
Operating Income (EBIT)13.3B10.5B2.6B2.5B2.1B
Non-Operating
Interest Income539.6M295.9M147.8M153.1M149.5M
Interest Expense73.4M74.4M190.8M212.3M102.7M
Net Interest Income394.0M221.5M(43.1M)(59.2M)46.7M
Other Non-Op Income/Expense177.4M203.3M69.5M(479.9M)204.4M
Non-Operating Income (excl Interest)66.4M57.6M36.9M267.6M86.7M
EBT (Pre-Tax Income)13.5B10.7B2.7B2.0B2.3B
Income Tax Expense2.1B1.7B500.5M392.2M370.7M
Bottom Line
Net Income10.6B8.5B2.1B1.5B1.9B
Earnings from Cont. Ops11.4B9.1B2.2B1.6B1.9B
Earnings from Discont. Ops
Bottom Line Net Income10.6B8.5B2.1B1.5B1.9B
Per Share
Basic EPSHK$4.30HK$3.43HK$0.86HK$0.62HK$0.78
Diluted EPSHK$4.27HK$3.43HK$0.85HK$0.62HK$0.74
Revenue Per ShareHK$10.59HK$7.18HK$3.70HK$3.20HK$2.66
Shares
Basic Shares Outstanding2.5B2.5B2.5B2.4B2.6B
Diluted Shares Outstanding2.6B2.5B2.5B2.4B2.6B
Profitability Metrics
EBITDA14.1B11.0B2.9B2.5B2.8B
D&A873.6M508.0M315.2M334.8M369.8M
EBIT13.2B10.5B2.6B2.2B2.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026